A mildly low eGFR can be normal aging, dehydration, muscle effects, or early kidney disease. The difference usually comes from trend, urine albumin, and whether creatinine is moving.
- eGFR normalne werty is usually 90–120 mL/min/1.73 m² in younger adults, but values around 60–75 can be seen in healthy adults over 70.
- Niski GFR below 60 mL/min/1.73 m² is not called chronic kidney disease unless it persists for at least 3 months or appears with kidney damage markers.
- Urine albumin-to-creatinine ratio below 3 mg/mmol, or below 30 mg/g, is generally normal; higher values change the risk meaning of any eGFR.
- Powtōrne badanie is usually needed within 1–2 weeks if eGFR suddenly drops, creatinine rises, potassium is high, or dehydration is possible.
- Age decline in eGFR averages roughly 0.7–1.0 mL/min/1.73 m² per year after midlife, though the slope varies widely.
- GFR test calculation depends on creatinine, age, sex, and sometimes cystatin C; it is an estimate, not a direct kidney measurement.
- Kontrola nyrek is more urgent with eGFR below 30, ACR above 30 mg/mmol with hematuria, or a fall above 5 mL/min/1.73 m² per year.
- sztuczno inteligyncyjo Kantesti reads eGFR alongside creatinine, BUN/urea, potassium, bicarbonate, albumin, urine markers, medications, and prior trends.
What counts as an eGFR normal range in adults?
An eGFR normalne werty is usually 90–120 mL/min/1.73 m² in younger adults, but a healthy 75-year-old may sit around 60–75 without urine albumin. Kidney numbers matter when eGFR stays below 60 for 3 months, drops quickly, or appears with albumin, blood in urine, high potassium, swelling, or rising creatinine. At sztuczno inteligyncyjo Kantesti, we interpret eGFR as a pattern, not a verdict.
Większość laboratoriów flaguje eGFR poniŏej 60 mL/min/1.73 m² because that threshold predicts higher kidney and cardiovascular risk when persistent. The catch is age: a stable eGFR of 58 in an 82-year-old with normal urine albumin is not the same clinical story as 58 in a 32-year-old.
Te Badanie GFR reported on routine chemistry panels is usually an estimated value calculated from creatinine, age, and sex. If you want the mechanics behind the calculation, our guide to GFR and eGFR explains why the estimate can mislead in muscular, frail, pregnant, or recently ill patients.
In my review work as Thomas Klein, MD, I see many patients worry after one eGFR of 62 or 68. A single mildly low kidney blood test is often a signal to repeat and check urine, not a reason to assume irreversible kidney disease.
As of April 26, 2026, KDIGO defines chronic kidney disease by kidney structure or function abnormalities lasting at least 3 months, including eGFR below 60 or markers such as albuminuria (KDIGO, 2024). That time requirement prevents overcalling temporary dehydration, medication effects, or lab variation.
Why eGFR falls with age without always meaning disease
eGFR naturally declines with age because kidney blood flow, nephron reserve, and tubular handling gradually change after midlife. A fall of about 0.7–1.0 mL/min/1.73 m² per year is common after the 40s, but the slope is not identical for everyone.
The kidneys are built with reserve capacity. Many people can lose a modest amount of filtration reserve over decades and still have normal potassium, normal acid-base balance, and no measurable urine albumin.
Aging also changes creatinine production. A thin 78-year-old may have a creatinine of 0.95 mg/dL and an eGFR near 58, while a muscular 45-year-old may show creatinine of 1.25 mg/dL with perfectly adequate true filtration.
The practical mistake is treating all eGFR values below 60 as identical. For older adults, our article on routine senior blood tests gives a more realistic frame: kidneys should be judged beside blood pressure, ACR, potassium, hemoglobin, diabetes markers, and medication burden.
In our analysis of 2M+ blood test uploads, we often see stable eGFR values in the low 60s over 4–6 years with no albuminuria. That pattern behaves very differently from a fall from 92 to 61 in 18 months, even though both can land near the same lab flag.
The age issue clinicians still debate
Clinicians disagree on whether the CKD threshold should be age-calibrated. KDIGO keeps the eGFR below 60 threshold because risk rises at a population level, but several nephrologists argue that older adults without albuminuria can be over-labeled if age is ignored.
My practical stance is boring but useful: I do not reassure a low eGFR until I have seen the urine ACR and the trend. Age explains some decline; it does not explain albumin leakage or a fast drop.
How the GFR test is calculated from a kidney blood test
The routine Badanie GFR is usually an estimated GFR calculated from serum creatinine, age, and sex, not a directly measured filtration study. A standard kidney blood test can estimate GFR in seconds, but the estimate can drift when creatinine production is unusual.
Creatinine is a muscle metabolism by-product that kidneys filter. If creatinine rises from 0.9 to 1.3 mg/dL, eGFR often falls meaningfully, but the interpretation depends on body size, muscle mass, hydration, and recent diet.
The 2021 race-free CKD-EPI equations improved fairness by removing race from eGFR reporting, and Inker et al. published creatinine and cystatin C equations in the New England Journal of Medicine that many health systems now use (Inker et al., 2021). Cystatin C is especially useful when muscle mass makes creatinine-based eGFR look too high or too low.
A direct measured GFR using iohexol, iothalamate, or nuclear medicine clearance is more accurate but rarely needed in routine primary care. It is usually reserved for kidney donation assessment, chemotherapy dosing, unusual body composition, or major disagreement between the lab number and the patient in front of us.
For a deeper look at creatinine itself, our guide to normal creatinine range explains why a result inside the lab range can still represent a meaningful change for a small older adult.
When a mildly low eGFR is expected rather than alarming
A mildly low eGFR between 60 and 89 mL/min/1.73 m² is often not kidney disease unless urine albumin, imaging, or urine sediment is abnormal. In adults over 70, a stable eGFR in the 50s can be low-risk when ACR is normal and no rapid decline is present.
I usually treat eGFR 60–89 as a context zone, not a disease label. If a 66-year-old has eGFR 72, ACR 1.2 mg/mmol, potassium 4.3 mmol/L, and stable creatinine for 5 years, the number is usually reassuring.
Borderline values are more suspicious in younger people. A 29-year-old with eGFR 68 should not be dismissed as normal aging, especially if there is hypertension, diabetes, recurrent urinary findings, or a family history of polycystic kidney disease.
Hydration can move creatinine enough to shift eGFR by 5–15 points in some patients. If your result followed vomiting, hard exercise, diuretic use, or a high-protein meal, our article on fałszywie wysokich wynikach przez odwodnienie may explain why creatinine looked temporarily worse.
One clinical trick: compare creatinine in absolute units, not only eGFR. An eGFR fall from 82 to 69 may look dramatic on a portal, but if creatinine shifted from 0.92 to 1.02 mg/dL during a hot week, I would often repeat before escalating.
The low-GFR-normal-creatinine pattern
A low eGFR with normal creatinine commonly happens in older adults because age is built into the equation. Our guide to niskie GFR przy normalnej kreatyninie covers the scenario that confuses patients most often.
The opposite pattern also occurs: creatinine may still sit inside the lab reference interval while eGFR has fallen meaningfully from a personal baseline. That is why trend history is often more useful than the bold red flag.
When low GFR needs repeat testing
Low GFR needs repeat testing when eGFR is below 60, suddenly falls by more than about 15–20%, or appears with abnormal potassium, bicarbonate, urine findings, or symptoms. A repeat kidney blood test within 1–2 weeks helps separate acute kidney stress from chronic change.
A first eGFR of 52 is not enough to diagnose chronic kidney disease unless it persists for at least 3 months. KDIGO 2024 keeps this duration rule because acute illness, dehydration, medications, and obstruction can all cause temporary drops.
Repeat sooner if creatinine rises quickly, potassium is above 5.5 mmol/L, bicarbonate is below 22 mmol/L, or there is new swelling, breathlessness, low urine output, or severe blood pressure elevation. Those patterns are not watch-and-wait findings.
NICE NG203 advises using repeat testing and ACR to classify CKD and recommends referral when eGFR is below 30, ACR is very high, or decline is accelerated (NICE, 2021). In practical clinic language, a fall above 5 mL/min/1.73 m² in 1 year is not something I shrug off.
If your report includes a basic metabolic panel, our guide to BMP blood tests explains why emergency clinicians look at creatinine, potassium, sodium, chloride, CO2, glucose, calcium, and urea together.
Why urine albumin changes the meaning of eGFR
Urine albumin can make a normal-looking eGFR clinically important. An ACR below 3 mg/mmol, or below 30 mg/g, is usually normal; persistent ACR above that suggests kidney filter stress even when eGFR is above 90.
The reason albumin matters is simple: eGFR estimates filtration volume, while ACR detects leakage through the glomerular barrier. A person can have eGFR 96 and ACR 12 mg/mmol, which is not a normal kidney risk pattern.
KDIGO classifies albuminuria as A1 below 30 mg/g, A2 from 30–300 mg/g, and A3 above 300 mg/g; in UK units, those cutoffs are roughly below 3, 3–30, and above 30 mg/mmol. The risk grid combines G category and A category because each predicts outcomes differently.
I often tell patients that eGFR is the drain speed and ACR is the filter leak. A slow drain with no leak may be age-related; a normal drain with a leak deserves diabetes, blood pressure, immune, and medication review.
Urine testing is easy to overlook because many panels stop at creatinine. Our poradnik do badania moczu covers albumin, protein, blood, specific gravity, glucose, ketones, and sediment clues that can change the kidney story.
eGFR trends I do not ignore
The most concerning eGFR result is often not the lowest number; it is the fastest fall. A sustained decline above 5 mL/min/1.73 m² per year, or above 10 over 5 years, usually deserves a structured kidney review.
A patient whose eGFR moves 88, 84, 81, 79 over 6 years often has a different risk profile from someone who moves 88, 74, 59 in 14 months. The second pattern makes me ask about NSAIDs, obstruction, diabetes, blood pressure, autoimmune disease, and recent infections.
Trend interpretation needs the same lab units and, ideally, the same equation. A switch from older CKD-EPI reporting to the 2021 race-free equation can change eGFR by several points without a biological change in filtration.
Kantesti AI tracks prior uploads so a new creatinine of 1.18 mg/dL is compared with your own baseline, not only the lab’s reference interval. Our historia badańo krwi feature is useful here because kidney risk often hides in slope, not one red mark.
The awkward bit: many health portals only show whether a value is high or low. For kidney numbers, the direction and speed of change are often more clinically useful than the color of the flag.
What I ask when the slope is steep
I ask about new blood pressure medicines, anti-inflammatory drugs, contrast scans, urinary symptoms, kidney stones, prostate or bladder outlet symptoms, and recent severe exercise. A fall above 20% after starting an ACE inhibitor or ARB may still be acceptable in some cases, but a fall above 30% usually needs prompt review.
The other question is whether albumin rose at the same time. A falling eGFR with rising ACR is a stronger signal than either result alone.
Medication, hydration, and exercise factors that bend eGFR
Many niskich GFR results are shaped by medicines, fluid status, and recent exercise rather than permanent nephron loss. NSAIDs, diuretics, ACE inhibitors, ARBs, creatine supplements, and heavy training can all change creatinine or kidney perfusion.
NSAIDs such as ibuprofen and naproxen can reduce kidney blood flow, especially in dehydration or when combined with ACE inhibitors and diuretics. The classic risk combination is sometimes called the triple whammy: NSAID plus ACE inhibitor or ARB plus diuretic.
ACE inhibitors and ARBs can cause a small early creatinine rise because they reduce pressure inside the kidney filter. A creatinine increase up to about 30% after starting treatment can be acceptable in selected patients, but it should be checked rather than ignored.
Exercise creates a different problem. I have reviewed marathon runners with creatinine up 15–25% after racing; our guide to athlete blood tests explains why timing matters before judging kidney function.
Protein intake and creatine supplements can also nudge creatinine upward without the same meaning as intrinsic kidney damage. If eGFR looks wrong for the person, cystatin C is often the cleaner tie-breaker.
Diabetes, blood pressure, and heart risk around kidney numbers
eGFR should be interpreted with diabetes, blood pressure, and cardiovascular risk because kidneys and blood vessels fail together more often than patients expect. ACR above 3 mg/mmol or eGFR below 60 changes long-term heart and kidney risk even before symptoms appear.
Diabetes is the commonest context where a normal eGFR can still hide kidney injury. A patient with HbA1c 8.2%, eGFR 102, and ACR 8 mg/mmol already has a kidney risk signal because albumin is leaking.
Blood pressure changes the slope. NICE and KDIGO both use albuminuria and eGFR stage to guide intensity of monitoring and treatment, and many patients with albuminuria are considered for ACE inhibitor or ARB therapy if appropriate.
Kidney results also reframe cholesterol and cardiovascular prevention. Reduced eGFR and albuminuria are independent cardiovascular risk markers, which is why I rarely review kidney numbers without also checking lipids and glycemic markers.
For diabetes context, our guide to Normalny zakres HbA1c explains why a borderline glucose marker can matter more when urine albumin is present. If blood pressure is the missing piece, see our zakresem ciśnienia krwi .
The kidney-heart connection patients underestimate
An eGFR of 55 with ACR 35 mg/mmol is not only a kidney issue; it is a vascular risk marker. The kidney filter is lined by tiny blood vessels, so albumin leak often reflects endothelial stress throughout the body.
This is why a kidney follow-up plan may include sodium review, blood pressure targets, statin discussion, diabetes treatment, smoking cessation, and medication reconciliation. It is not just about drinking more water.
What to ask your clinician after a low GFR result
After a low GFR result, ask whether the value is new, persistent, or paired with albuminuria. The most useful next tests are repeat creatinine/eGFR, urine ACR, urinalysis, potassium, bicarbonate, calcium/phosphate when indicated, and sometimes cystatin C.
A good first question is: what was my eGFR last year? If nobody can answer, you are interpreting a moving biomarker without knowing its direction.
A second question is: do I have albumin in my urine? ACR is inexpensive, often more predictive than patients realize, and can turn a bland eGFR result into a genuine risk marker.
A third question is medication safety. Ask specifically about NSAIDs, diuretics, ACE inhibitors, ARBs, SGLT2 inhibitors, metformin thresholds, contrast imaging, and dose adjustments for medicines cleared by the kidney.
Nasz badanie krwi na nerki guide covers early shifts before creatinine rises, and the Wspōłczynnik BUN do kreatyniny guide helps separate dehydration patterns from intrinsic kidney clues.
How Kantesti AI reads eGFR in the full lab pattern
Kantesti AI interprets eGFR by combining the kidney number with creatinine, urea/BUN, electrolytes, albumin, urine markers, age, sex, prior results, and medication context. Our AI does not treat a single eGFR as a diagnosis; it grades urgency and suggests what to verify next.
When you upload a PDF or photo, Kantesti’s neural network reads the reported units, flags the lab method, and compares the value with age-aware patterns. It can usually return an interpretation in about 60 seconds through our AI analiza krwi.
The system is designed to catch combinations that patients miss: eGFR 63 plus potassium 5.7 mmol/L, creatinine rising 22%, or ACR above 30 mg/mmol. That is different from simply saying low or normal.
Nasz walidacyjo medyczno framework prioritizes avoiding false reassurance in urgent patterns and avoiding overdiagnosis traps in borderline ones. I, Thomas Klein, MD, prefer that balance because kidney anxiety is common, but missed acute kidney injury is worse.
You can test your own report with our darmowego blood test analysis. If your result is urgent, symptomatic, or rapidly worsening, use Kantesti as a second explanation layer, not a substitute for same-day medical care.
What our AI still cannot know from a PDF
No AI can feel a bladder, measure fluid status, confirm urine output, hear your full medication history, or see a kidney ultrasound from a chemistry panel alone. That is why our platform gives next-step logic rather than pretending the lab report contains the whole diagnosis.
The best use case is pattern recognition plus preparation for a clinician visit. Uploading past reports improves the signal because kidney interpretation is trend-heavy.
A practical monitoring schedule by eGFR category
Monitoring frequency depends on eGFR stage, urine albumin, and rate of change. A stable eGFR above 60 with normal ACR may only need annual review, while eGFR below 30 or high albuminuria usually needs specialist involvement.
Dla eGFR 60–89 with ACR below 3 mg/mmol, annual monitoring is often enough if blood pressure, diabetes risk, and medicines are stable. I would shorten that interval if creatinine is rising, the patient is starting a new kidney-active medication, or urine findings change.
Dla eGFR 45–59, many clinicians repeat in 3 months to confirm chronicity and add ACR if it has not been checked. If ACR is normal and the patient is older, the follow-up may remain primary-care based.
Dla eGFR 30–44, monitoring commonly moves to every 3–6 months, depending on albuminuria, potassium, bicarbonate, hemoglobin, and blood pressure. The risk is not only kidney failure; anemia, acidosis, bone-mineral changes, and drug accumulation start to matter more.
For a wider view of what a kidney panel includes, our panel badani funkcji nyrk guide explains creatinine, urea, electrolytes, calcium, phosphate, albumin, and CO2 in one place.
Research publications and medical review behind this guide
Kantesti’s eGFR guidance is physician-reviewed and aligned with current kidney guidelines, but it remains educational rather than a personal diagnosis. Our medical content is reviewed through the Rada Doradczo Medyczno and updated when major laboratory or guideline standards change.
Kantesti LTD is a UK company building AI-powered blood test interpretation for patients, clinicians, and partners across 127+ countries. You can read more about the organization on Ô Kantesti, including our governance and product direction.
Kantesti LTD. (2026). Clinical Validation of the Kantesti AI Engine (2.78T) on 15 Anonymised Blood Test Cases: A Pre-Registered Rubric-Based Benchmark Including Hyperdiagnosis Trap Cases Across Seven Medical Specialties. Figshare. DOI. ResearchGate: Brama Podszukowań. Academia.edu: Akadymijo.edu.
Kantesti LTD. (2026). AI Blood Test Analyzer: 2.5M Tests Analyzed | Global Health Report 2026. Zenodo. DOI. ResearchGate: ResearchGate profile. Academia.edu: Academia profile.
For technical readers, our public benchmark page explains how Kantesti AI handles trap cases, multi-specialty patterns, and borderline results in a pre-registered scoring framework. See the AI benchmark za szczegōły.
Czynsto zadawane pytania
Co je normalne eGFR po wiekù?
Normalny eGFR je zwykle około 90–120 mL/min/1.73 m² u młodszych dorosłych, około 75–105 w midlife, a często 60–90 po 60. roku życia. Niychtóre zdrowe dorośle po 70 mają stabilne wartości eGFR na poziomie około 50–75 bez albuminy w moczu. Liczba je barzij niepokojōnca, jak je poniży 60 przynajmni 3 miesiōnce, spada rychło, abo je widoczna z albuminuriō, krwiō w moczu, wysōkim potasem, abo rosnōcym kreatyninō.
Czy eGFR 60 je zle dla 70-latka?
EGFR na poziomie około 60 mL/min/1,73 m² u 70-latka moze być zgodny z spadkiem spowodowanym wiekiem, jeźli je stabilny i ACR w moczu je poniży 3 mg/mmol abo poniży 30 mg/g. Robi sie to bardziej niepokojące, jeźli eGFR spada o wiyncyj niź 5 mL/min/1,73 m² na rok, potas je wysoki, ciśnienie krwi je słabo kontrolowane, abo w moczu je albumina. Wiyncy lekarzy by powtórzyli badanie funkcji nyrek z krwi i dodali albuminę w moczu, zanim podejmą twardą ocenę ryzyka.
Czy odwodnienie moze powodować niskie eGFR?
Jo, odwodnienie moze tymczasowo zniżyć eGFR, bo podnosi kreatyninę, zwłaszcza po wymiotach, biegunkach, mocnym spocie, braniu leków moczopędnych abo przy słabym piciu. Zmiana moze być umiarkowana, na przikład 5–15 punktów eGFR, ale większe przesunięcia mogōm sie zdarzyć w czasie ostrej choroby. Jeźli podejrzewōmy odwodnienie i pacjent je ôstały w inakszym sensie, to lekarze często powtarzajōm kreatyninę/eGFR w 1–2 tygodnie po nawodnieniu i przeglōdzie leków.
Co znaczy poziōm eGFR w chorobie nerek w przewlekłym przebiegu?
Przewlekła choroba nyrek zwykle je rozpoznawana, jak eGFR ôstaje poniżej 60 mL/min/1.73 m² przynajmni 3 miesiōnce abo jak markery uszkodzynia nyrek, takie jak albuminuria, trwajōm. eGFR 45–59 je CKD stopnia G3a, jeżl je to stałe, a eGFR 30–44 to G3b, natomiast eGFR poniżej 30 je wiyncy ryzyka. Potrzebny je moczowy ACR, bo sam eGFR nie pokazuje, czy filtra nyrek przecieka albumina.
Kiedy mam sie martwić o niskie GFR?
Niski GFR je wiyncyj niepokōjōcy, jak eGFR je niy wiyncyj niž 60, a nowy, poniżej 30 w každyj wiece, spada o wiyncyj niž 5 mL/min/1.73 m² na rok, abo je sparowany z ACR powyżej 30 mg/mmol, krw w moczu, potas powyżej 5.5 mmol/L, abo z symptōmami, takimi jak puchniycie abo mała ilość moczu. Jedno lekko niskie werty po odwodnieniu, ciynzkij fizycznej robocie abo zmianie leku moze byc czasowe. Ponowne badanie i albumina w moczu zwykle wyjaśniajō ryzyko.
Jaka je rōznica miyndzy kreatyninōm a eGFR?
Kreatynina je zbytek, kery se mjeri bezpośredno we krwi, a eGFR je obliczōny odhad filtracyje nerek, oparty gōłownie na kreatyninie, wiku i płci. Kreatynina 1.1 mg/dL może znaczyć rōżne wartości eGFR u 30-latka, 80-latka, silych sportowca abo słabego dorosłego. Cystatyna C może pomōc potwierdzić funkcyje nerek, gdy eGFR na bazie kreatyniny nie pasuje do klinicznego obrazu.
Czy mam prosić o albumin w moczu, jezli mój eGFR je niski?
Tak, stosunek albuminy do kreatyniny w moczu je jedyn z najbarzijej użytecznych testów kontrolnych po niskim abo granicznym eGFR. ACR poniżej 3 mg/mmol, abo poniżej 30 mg/g, je z reguły normlany, a natomiast trwajōcy ACR powyżej tego poziomu sugeruje wzrost ryzyka chorób nerek i sercowo-naczyniowych. ACR może być nieprawidłowy nawet wtedy, gdy eGFR je powyżej 90, przeto dodaje informacyje, których sam test krwi na nerki nie potrafi dostarcyć.
Zdobōdź analizō krwi z AI dzisiaj
Dołącz do wiyncyj niż 2 milionōw użytkownikōw na całym świecie, co ufajōm Kantesti za natychmiastowō i dokładnō analizō badań labolatoryjnych. Wgraj swoje wyniki badańo krwi i dostōń kompleksowō interpretacyjo biomarkerōw 15,000+ w sekundach.
📚 Publikacyje badawcze z referencjami
Klein, T., Mitchell, S., & Weber, H. (2026). Kliniczna walidacyjo Kantesti AI Engine (2.78T) na 15 anonimowych przypadkach badańo krwi: benchmark w oparciu o rubryki, wstępnie zarejestrowany, z pułapkōm nadrozpoznanio we siedmiu dziedzinach medycyny. Kantesti AI Medical Research.
Klein, T., Mitchell, S., & Weber, H. (2026). AI analiza krwi: 2.5M testōw przeanalizowanych | Globalny raport zdrowio 2026. Kantesti AI Medical Research.
📖 Zewnętrzne medyczne referencyje
KDIGO CKD Guideline Work Group (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International.
National Institute for Health and Care Excellence (2021). Chronic kidney disease: assessment and management. NICE guideline NG203. Wytyczne NICE.
⚕️ Uchylynie ôd ôdpowiedzialności medycznyj
Ten artykuł je wyłōncznie do celōw edukacyjnych i nie stanowi porady medyczno. Zawsze skonsultuj się z wykwalifikowanym pracownikiem ochrony zdrowio w sprawie decyzji o diagnozie i leczeniu.
Sygnały zaufanio E-E-A-T
Doświadczynie
Kliniczny przeglōnd prowadzōny przez lekarza w ramach procydur interpretacyje wynikōw laboratorijnych.
Ekspertyza
Skupiyńce na medycynie laboratorijnej: jak biomarkery zachowujōm sie w klinicznym kontekście.
Autorytetność
Napisane przez dr. Thomasa Kleina z przeglōndym przez dr. Sarah Mitchell i prof. dr. Hansa Webera.
Godność
Interpretacyja na bazie dowodōw z jasnymi ścieżkami dalszego postępowania, coby zredukujōć alarm.